News - BioSpace
WEBSeptember 12, 2024. ·. 4 min read. ·. Angela Gabriel. Load More. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news ...
HEK 293 Cells: Background, Advantages and Applications
WEBJun 18, 2021 · Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are popular because they are fast-growing and robust. Additionally, due to the efficiency of HEK 293 cells, they generate exogenous proteins used in biomedical and pharmaceutical research.
BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEB2024 Q2 Job Market Report: More People Competing for Fewer Job Openings. For the second quarter of 2024, there were 25% fewer jobs posted live on BioSpace compared to the same quarter of 2023. The year-over-year job response rate rose from 14.6% to 15.3%. July 11, 2024. ·.
AstraZeneca’s Imfinzi Scores Lung Cancer Wins With FDA’s
WEBAug 16, 2024 · AstraZeneca touted two lung cancer victories on Thursday with its blockbuster PD-1 inhibitor Imfinzi (durvalumab) securing the FDA’s nod for a perioperative label expansion in non-small cell lung cancer, as well as the regulator’s Priority Review and Breakthrough Therapy designations for small cell lung cancer.. The perioperative approval came as a bit of a surprise.
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
WEBAug 14, 2024 · Eli Lilly on Tuesday debuted in America’s biggest biotech hub—Boston—with a new facility dedicated to the research and development of cutting-edge genetic therapies. Dubbed the Lilly Seaport Innovation Center (LSC), the new site will expand the pharma’s U.S. footprint by 346,000 square feet and will be able to house 500 scientists and ...
Novo’s Semaglutide Potentially Linked to Higher Risk of Suicidal ...
WEBAug 21, 2024 · Novo Nordisk ’s blockbuster GLP-1 treatment semaglutide—sold as Ozempic for type 2 diabetes and Wegovy for obesity—appears to be associated with a higher risk of suicidal ideation versus other drugs, according to a new study that drew from the World Health Organization’s safety database.. The results, published Tuesday in JAMA Network Open, are based on the WHO’s repository which ...
8 Best Cities In The US Offering Biotech Jobs - BioSpace
WEBJul 16, 2021 · 8. New York and New Jersey. Other cities that are ideal locations to find biotech jobs are New York and New Jersey. New York is the largest city in the United States, with an extensive health system employing 14,000 life science professionals. The city plans a $100 million “Applied Life Sciences Hub” with a $500 million ten-year deal to ...
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for ...
WEBAug 14, 2024 · Imfinzi is an intravenous PD-L1 blocking antibody that works by preventing the ligand’s interaction with its receptor, disrupting the cancer cells’ ability to evade and suppress the immune system. The mechanism of action also boosts the anti-cancer activity of T-cells. Imfinzi is indicated for various cancers including non-small cell lung ...
The Top 6 Pharmaceutical Companies in New Jersey - BioSpace
WEBJun 23, 2017 · 6. Bristol Myers Squibb. New York City, N.Y. Jobs. 1. Johnson & Johnson. Johnson & Johnson has remained in the top spot on this list for many years. The company is headquartered in New Brunswick, NJ and employs over 140,000 people worldwide. J&J’s products include over-the-counter medications, medical devices and …
Novartis, Versant Launch RNA Kidney Medicines—Focused Borealis
WEBAug 22, 2024 · Novartis and Versant Ventures unveiled Borealis Biosciences Thursday with $150 million in combined Series A financing and strategic research collaboration funding to target next-generation RNA medicines for kidney diseases.. The Borealis collaboration builds on a previous kidney disease company. Five years ago, Versant launched Chinook Therapeutics. In 2023, Novartis dropped $3.2 billion, with ...